UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
(MARK ONE)
[x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended APRIL 30, 1995
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 0-2537
OPTICAL COATING LABORATORY, INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation or organization)
68-0164244
(I.R.S. Employer Identification No.)
2789 NORTHPOINT PARKWAY, SANTA ROSA, CA 95407-7397
(Address of principal executive offices)
(707) 545-6440
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days. Yes X No
APPLICABLE ONLY TO CORPORATE ISSUERS
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.
Classes of Common Stock
COMMON STOCK, $.01 PAR VALUE
Outstanding at May 31, 1995: 9,066,220 shares
This document contains 65 pages.
The Exhibit listing appears on Page 16-17
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized and in the capacity indicated.
OPTICAL COATING LABORATORY, INC.
(Registrant)
July 19, 1995 /s/ JOHN M. MARKOVICH
Date John M. Markovich
Vice President Finance and
Chief Financial Officer
(Principal Financial Officer)
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0000074697
<NAME> OCLI
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> OCT-31-1995
<PERIOD-END> APR-30-1995
<CASH> 5,467
<SECURITIES> 0
<RECEIVABLES> 27,782
<ALLOWANCES> 1,501
<INVENTORY> 12,884
<CURRENT-ASSETS> 53,783
<PP&E> 61,667
<DEPRECIATION> 70,996
<TOTAL-ASSETS> 126,387
<CURRENT-LIABILITIES> 33,648
<BONDS> 0
<COMMON> 90
0
0
<OTHER-SE> 56,171
<TOTAL-LIABILITY-AND-EQUITY> 126,387
<SALES> 77,480
<TOTAL-REVENUES> 77,480
<CGS> 47,275
<TOTAL-COSTS> 47,275
<OTHER-EXPENSES> 22,128
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1,911
<INCOME-PRETAX> 6,588
<INCOME-TAX> 2,766
<INCOME-CONTINUING> 3,822
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 3,822
<EPS-PRIMARY> 0.44
<EPS-DILUTED> 0.44
</TABLE>
